Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface

Current Opinion in Cell Biology

Volumn 8, Issue 5, 1996, Pages 731-738

  Basbaum, Carol B ^a   Werb, Zena ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADEMALYSIN; ASTACENE; CELL SURFACE PROTEIN; CELL SURFACE RECEPTOR; METALLOPROTEINASE; SCLEROPROTEIN; SERINE PROTEINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; CELL DIFFERENTIATION; CELL INVASION; CELL MATURATION; CELL MOTILITY; CELL TRANSFORMATION; CONTROLLED STUDY; ENZYME ACTIVATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; MESENCHYME CELL; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW;

ANIMALIA;

EID: 0030271595     PISSN: 09550674     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-0674(96)80116-5     Document Type: Article

References (63)

1. Birkedal-Hansen H: Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 1995, 7:728-735.
2. Wolfsberg TG, Straight PD, Gerena RL, Huovila AP, Primakoff P, Myles DG, White JM: ADAM, a widely distributed and developmentally regulated gene family encoding membrane proteins with disintegrin and metalloprotease domain. Dev Biol 1995, 169:378-383. This review describes and classifies the ADAM subfamily of transmembrane proteins which contain metalloproteinase and disintegrin domains.
3. Adams JC, Watt FM: Regulation of development and differentiation by the extracellular matrix. Development 1993, 117:1183-1198.
4. Alexander CM, Werb Z: Extracellular matrix degradation. In Cell Biology of Extracellular Matrix, edn 2. Edited by Hay ED. New York: Plenum Press; 1991:255-302.
5. Monsky WL, Chen WT: Proteases of cell adhesion proteins in cancer. Semin Cancer Biol 1993, 4:251 -258.
6. Ashkenas J, Damsky CH, Bissell MJ, Werb Z: Integrins, signaling and the remodeling of the extracellular matrix. In Integrins. Molecular and Biological Responses to the Extracellular Matrix. Edited by Cheresh DA, Mecham RP. San Diego: Academic Press; 1994:79-109.
7. Bond JS, Beynon RJ: The astacin family of metalloendopeptidases. Protein Sci 1995, 4:1247-1261.
8. Mignatti P, Rifkin D: Biology and biochemistry of proteinases in tumor invasion. Physiol Rev 1993, 73:161-195.
9. Scanlan MJ, Raj BK, Calvo B, Garin-Chesa P, Sanz-Moncasi MP, Healey JH, Old U, Rettig WJ: Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Proc Natl Acad Sei USA 1994, 91:5657-5661.
10. Saneshige S, Mano H, Tezuka K, Kakudo S, Mori Y, Honda Y, Itabashi A, Yamada T, Miyata K, Hakeda Y et al.: Retinoic acid directly stimulates osteoclastic bone resorption and gene expression of cathepsin K/OC2. Biochem J 1995, 309:721-724.
11. Sato H, Takino T, Okada Y, Cao J, Shinagawa A, Yamamoto E, Seiki M: A matrix metalloproteinase expressed on the surface of invasive tumor cells. Nature 1994, 370:61-65.
12. Will H, Hinzmann B: cDNA sequence and mRNA distribution of a novel human matrix metalloproteinase with a potential transmembrane segment Eur J Biochem 1995, 231:602-608. See annotation [14].
13. Takino T, Sato H, Shinagawa A, Seiki M: Identification of the second membrane-type matrix metalloproteinase (MT-MMP-2) gene from a human placenta cDNA library. MT-MMPs form a unique membrane-type subclass in the MMP family. J Biol Chem 1995, 270:23013-23020. See annotation [14].
14. Puente XS, Pendas AM, Llano E, Velasco G, Lopez-Otin C: Molecular cloning of a novel membrane-type matrix metalloproteinase from a human breast carcinoma. Cancer Res 1996, 56:944-949. This study and [12,13] describe three new members of the MT-MMP family.
15. Sang QA, Douglas DA: Computational sequence analysis of matrix metalloproteinases. J Prot Chem 1995, 15:137-160.
16. Rouille Y, Duguay SJ, Lund K, Furuta M, Gong Q, Lipkind G, Oliva AA Jr, Chan SJ, Steiner DF: Proteolytic processing mechanisms in the biosynthesis of neuroendocrine peptides: the subtilisin-like proprotein convertases. Frontiers Neuroendocrinol 1995, 16:322-361.
17. Fenouillet E, Jones IM: The glycosylation of human immunodeficiency virus type 1 transmembrane glycoprotein (gp41) is important for the efficient intracellular transport of the envelope precursor gp160. J Gen Virol 1995, 76:1509-1514.
18. Pei D, Weiss S: Furin-dependent intracellular activation of the human stromelysin-3 zymogen. Nature 1995, 375:244-247.
19. Marchand P, Tang J, Johnson GD, Bond JS: COOH-terminal proteolytic processing of secreted and membrane forms of the alpha subunit of the metalloprotease meprin A. Requirement of the I. domain for processing in the endoplasmic reticulum. J Biol Chem 1995, 270:5449-5456.
20. Strongin AY, Collier I, Bannikov G, Marmer BL, Grant GA, Goldberg Gl: Mechanism of cell surface activation of 72-kDa type IV collagenase. Isolation of the activated form of the membrane metalloprotease. J Biol Chem 1995, 270:5331-5338.
21. Atkinson SJ, Crabbe T, Cowell S, Ward RV, Butler MJ, Sato H, Seiki M, Reynolds JJ, Murphy G: Intermolecular autolytic cleavage can contribute to the activation of progelatinase A by cell membranes. J Biol Chem 1995, 270:30479-30485. This study shows that MT-MMP-1 is inhibited far less efficiently by TIMP-1 than it is by TIMP-2. As TIMP-2 is expressed constitutively, whereas the expression of TIMP-1 is regulated, the finding of differential inhibition implies that MT-MMP-1 may be active in cell surface proteolysis even in the presence of high concentrations of TIMP-1.
22. Logan SK, Garabedian MJ, Campbell C, Werb Z: Synergistic transcriptions! activation of the TIMP-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors. J Biol Chem 1996, 271:774-782.
23. Okada A, Bellocq J-P, Rouyer N, Chenard M-P, Rio M-C, Chambon P, Basset P: Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinoma. Proc Natl Acad Sei USA 1996, 92:2730-2734.
24. Zucker S, Conner C, Dimassmo BL, Ende H, Drews M, Seiki M, Bahou WF: Thrombin induces activation of progelatinase A in vascular endothelial cells - physiologic regulation of angiogenesis. J Biol Chem 1995, 270:23730-23738.
25. Stahl A, Mueller BM: The urokinase-type plasminogen activator receptor, a GPI-linked protein is localized in caveolae. J Cell Biol 1995, 129:335-344.
26. Bugge TH, SuhTT, Rick MJ, Daugherty CC, Romer J, Solberg H, Ellis V, Dano K, Degen JL: The receptor for urokinase-type plasminogen activator is not essential for mouse development or fertility. J Biol Chem 1995, 270:16886-16894.
27. Kessler E, Takahara K, Biniaminov L, Brusel M, Greenspan DS: Bone morphogenetic protein-1 : the type I procollagen C-proteinase. Science 1996, 271:360-362. This study shows that the carboxy-terminal propeptide of procollagen is a substrate for mammalian BMP-1 /tolloid, a protein necessary for development in Drosophila. The data, therefore, link ECM regulation with development via this astacin family metalloproteinase.
28. Finelli AL, Xie T, Bossie CA, Blackman RK, Padgett RW: The tolkin gene is a tolloid/BMP-1 homologue that is essential for Drosophila development Genetics 1995, 141:271-281. BMP-1 /tolloid/tolkin have amino-terminal metalloproteinase domains. In Drosophila, the proteinases activate the TGF-β superfamily homolog decapentaplegic, which specifies the dorsal-ventral axis in the embryo.
29. Scott 1C, Halila R, Jenkins JM, Mehan S, Apostolou S, Winqvist R, Gallen DF, Prockop DJ, Peltonen L, Kadier KE: Molecular cloning, expression and chromosomal localization of a human gene encoding a 33 kDa putative metallopeptidase (PRSM-1). Gene 1996, in press. This paper reports the cloning of the gene encoding a new metalloproteinase, which is a procollagen peptidase. On the basis of proteolytic activity assays, this enzyme is the first member of this subfamily of extracellular proteinases that is found in mammals. The fact that these metalloproteinases process procollagen to collagen indicates that they may have important physiological functions.
30. Singer II, Kawka DW, Bayne EK, Donatelli SA, Wiedner JR, Williams HK, Ayala JM, Mumford RA, Lark MW, Giant TT et al.: VDIPEN, a metalloproteinase-generated neoepitope, is induced and immunolocalized in articular cartilage during inflammatory arthritis. J Clin Invest 1995, 95:2178-2186.
31. Rice A, Banda MJ: Neutrophil elastase processing of gelatinase A is mediated by extracellular matrix. Biochemistry 1995, 34:9249-9256.
32. Kelly T, Mueller SC, Yeh Y, Chen WT: Invadopodia promote proteolysis of a wide variety of extracellular matrix proteins. J Cell Physiol 1994, 158:299-308.
33. Brooks P, Stromblad S, Sanders L, Von Schalscha T, Aimes R, Stetler-Stevenson W, Quigley J, Cheresh D: Localization of matrix metalloproteinase MMP-2 to the surface of invasive cells by interaction with integrin αvβ3. Cell 1996, 85:683-693.
34. Wei Y, Lukashev M, Simon DI, Rosenberg S, Doyle MV, Chapman HA: Regulation of integrin function by the receptor for urokinase. Science 1996, in press.
35. Lund LR, Romer J, Thomasset N, Solberg H, Pike C, Bissell MJ, Dano K, Werb Z: Two distinct phases of apoptosis in mammary gland involution: proteinase-independent and -dependent pathways. Development 1996, 122:181-193. This study shows that proteinases produced by stromal cells degrade the basement membrane underlying mammary epithelial cells, inducing the apoptotic death of the epithelial cells during involution. Thus, this proteolytic process is a specialized mesenchymal-epithelial interaction that regulates cell differentiation, function and viability.
36. Lim M, EKman F, Dohrman A, Cunha G, Basbaum C: Upregulation of the 72-kDa type IV collagenase in epithelial and stromal cells during rat tracheal gland morphogenesis. Dev Biol 1995, 171:521-530. This paper shows that the cells at the leading edge of invading tracheal gland epithelia express gelatinase A. Therefore, even in an environment in which the stromal cells express large quantities of this proteinase, local proteolysis by the growing tip of the epithelium may be important.
37. Romer J, Bugge TH, Pike C, Lund LR, Flick MJ, Degen JL, Dano K: Impaired wound healing in mice with a disrupted plasminogen gene. Nat Med 1996, 2:287-292. This study shows that plasminogen-null mice display a profound defect in wound healing. In the absence of this proteinase, keratinocytes fail to migrate and proliferate to cover the area of injury. Although the mechanism underlying the defective keratinocyte function has not been elucidated, the data suggest that proteolysis of the provisional fibrin matrix is required. These data point to a critical role for plasminogen, and, by inference, plasminogen activators, in wound repair.
38. Roskelley CD, Desprez PY, Bissell MJ: Extracellular matrixdependent tissue-specific gene expression in mammary epithelial cells requires both physical and biochemical signal transduction. Proc Natl Acad Sei USA 1994, 91:12378-12382.
39. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z; Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J CellBiol 1994, 125:681-693.
40. Boudreau N, Sympson CJ, Werb Z, Bissell MJ: Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix Science 1995, 267:891-893.
41. Alexander CM, Hansell EJ, Behrendtsen O, Rannery ML, Kishnani NS, Hawkes SP, Werb Z: Expression and function of matrix metalloproteinases and their inhibitors at the maternal-embryonic boundary during mouse embryo implantation. Development 1996, 122:1723-1736. This study shows that regulation of TIMP-3 underlies the programmed cell death of maternal decidua during implantation. The authors also used TIMP-1 transgenic mice to demonstrate the requirement for MMPs in decidua for growth and angiogenesis at the maternal-fetal interface. These data give the first direct insight into MMP action during a normal invasive event.
42. Biswas C, Zhang Y, DeCastro R, Guo H, Nakamura T, Kataoka H, Nabeshima K: The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily. Cancer Res 1995, 55:434-439.
43. Seulberger H, linger CM, Risau W: HT7, Neurothelin, basigin, gp42 and OX-47 -many names for one developmentally regulated immunoglobulin-like surface glycoprotein on blood-brain barrier endothelium, epithelial tissue barriers and neurons. Neurosci Lett 1992, 140:93-97.
44. Fisher CJ, Datta SC, Talwar HS, Wang Z-Q, Varani J, Kang S, Vorhees II: Molecular basis of sun-induced premature skin aging and retinoid antagonism. Nature 1996, 379:335-339.
45. D'Armiento J, DiColandrea T, Dalai SS, Okada Y, Huang M-T, Conney AH, Chada K: Collagenase expression in transgenic mouse skin causes hyperkeratosis and acanthosis and increases susceptibility to tumorigenesis. Mol Cell Biol 1995, 15:5732-5739.
46. Sympson CJ, Bissell MJ, Werb Z: Mammary gland tumor formation in transgenic animals overexpressing stromelysin-1. Semin Cancer Biol 1995, 6:159-164.
47. Montgomery AM, Reisfeld RA, Cheresh DA: Integrin αvβ3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. Proc Natl Acad Sci USA 1994, 91:8856-8860.
48. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z, Damsky CH: Cooperative signaling by α5β1 and α4β1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 1995, 129:867-879.
49. Corcoran ML, Kibbey MC, Kleinman HK, Wahl LM: Laminin SIKVAV peptide induction of monocyte macrophage prostaglandin E2 and metalloproteinases. J Biol Chem 1995, 270:10365-10368.
50. Riikonen T, Westermarcle J, Koivisto L, Broberg A, Kahan VM, Heino J: Integrin α2β1 is a positive regulator of collagenase (MMP-1) and collagen α1(I) gene expression. J Biol Chem 1995, 270:13548-13552.
51. Liu X, Wu H, Byrne M, Jeffrey J, Krane S, Jaenisch R: A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling. J Cell Biol 1995, 130:227-237.
52. Watson SA, Morris TM, Robinson G, Crimmin MJ, Brown PD, Hardcastle JD: Inhibition of organ invasion by the matrix metalloproteinase inhibitor batimastat (BB-94) in two human colon carcinoma metastatic models. Cancer Res 1995, 55:3629-3633.
53. Tracey K, Cerami A: Tumor necrosis factor, other cytokines and disease. Annu Rev Cell Biol 1993, 9:31 7-443.
54. Perez C, Albert I, DeFay K, Zachariades N, Gooding L, Kriegler M: A nonsecretable cell surface mutant of tumor necrosis factor (TNF) kills by cell-to-cell contact Cell 1990, 63:251-258.
55. Crowe P, Walter B, Mohler K, Otten-Evans C, Black R, Ware C: A metalloprotease inhibitor blocks shedding of the 80-kD TNF receptor and TNF processing in T lymphocytes. J Exp Med 1995, 181:1205-1210.
56. Black RA, Durie FH, Otten-Evans C, Miller R, Slack JL, Lynch DH, Castner B, Mohler KM, Gerhart M, Johnson RS et al.: Relaxed specificity of matrix metalloproteinases (MMPs) and TIMP-insensitivity of tumor necrosis factor-α (TNF-α) production suggest the major TNF-α converting enzyme is not an MMP. Biochem Biophys Res Commun 1996, in press.
57. Kojro, E, Fahrenholz F: Ligand-induced cleavage of the V-2 vasopressin receptor by a plasma membrane metalloproteinase. J Biol Chem 1995, 270:6476-6481.
58. Mullberg J, Durie F, Otten-Evans C, Alderson M, Rose-John S, Cosman D, Black R, Mohler K: A metalloprotease inhibitor blocks shedding of the IL-6 receptor and the p60 TNF receptor. J Immunol 1995, 155:5198-5205.
59. Stocker W, Grams F, Baumann U, Reinemer P, Gomis-Ruth F-X, McKay DB, Bode W: The metzincins-topological and sequential relations between astacins, adamalysins, serralysins and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Svi 1995, 4:823-840. This excellent review defines the structural relationships of all the zinc-dependent metalloproteases.
60. Rooke J, Pan D, Xu T, Rubin GM: KUZ, a conserved metalloprotease/disintegrin protein with two distinct roles during Drosophila neurogenesis. Science 1996, in press. This study shows that an ADAM family protein with metalloprotease/disintegrin domains is required for lateral inhibition in partitioning of neural and non-neuronal cells during development of central and peripheral nervous systems in Drosophila. In the absence of kuz, all of the cells assume a neural fate. Development of a neuron also requires a Kuz-mediated positive soluble signal from neighboring cells. This gene is highly conserved, with a bovine brain homolog (the gene encoding ADAM 10) sharing 43% sequence identity. The bovine gene has previously been shown to encode a protease able to digest myelin basic protein, kuz is the first gene of this subfamily for which the accompanying mutant phenotype has been characterized.
61. Shipley JM, Wesselschmidt RL, Kobayashi DK, Ley TJ, Shapiro SD: Metalloelastase is required for macrophage-mediated proteolysis and matrix invasion in mice. Proc Natl Acad Sci USA 1996, 93:3942-3946.
62. Lyons-Giordano B, Lazarus GS: Skin abnormalities in mice transgenic for plasminogen activator inhibitor 1: implications for the regulation of desquamation and follicular neogenesis by plasminogen activator enzymes. Dev Biol 1995, 170:289-298.
63. Soloway P, Alexander CM, Werb Z, Jaenisch R: Targeted mutagenesis of TIMP-1 reveals that experimental metastasis is influenced by the TIMP-1 genotype of the tumor but not by that of the host Oncogene 1996, in press.